APA (7th ed.) Citation

Yoshino, T., Siena, S., Dalal, R., Okuda, Y., Yamamoto, E., & Grothey, A. (2018). A multicenter, multicohort, phase II study of trastuzumab deruxtecan (DS-8201a) in subjects with HER2-expressing metastatic colorectal cancer. Annals of oncology, 29, ix45. https://doi.org/10.1093/annonc/mdy431.057

Chicago Style (17th ed.) Citation

Yoshino, T., S. Siena, R. Dalal, Y. Okuda, E. Yamamoto, and A. Grothey. "A Multicenter, Multicohort, Phase II Study of Trastuzumab Deruxtecan (DS-8201a) in Subjects with HER2-expressing Metastatic Colorectal Cancer." Annals of Oncology 29 (2018): ix45. https://doi.org/10.1093/annonc/mdy431.057.

MLA (9th ed.) Citation

Yoshino, T., et al. "A Multicenter, Multicohort, Phase II Study of Trastuzumab Deruxtecan (DS-8201a) in Subjects with HER2-expressing Metastatic Colorectal Cancer." Annals of Oncology, vol. 29, 2018, p. ix45, https://doi.org/10.1093/annonc/mdy431.057.